🔎 Trials Near Me

Inicio › Obesidad › Texas › Houston

Ensayos clínicos de Obesidad en Houston, TX

44 estudios para Obesidad buscan participantes en centros de Houston y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.

Texto oficial del estudio (inglés)

¿Reclutando participantes para un estudio? Destácalo en la parte superior de esta página — $99 por 30 días →

Home Self-administration of Maridebart Cafraglutide With Autoinjector in Adults Living With Obesity or Overweight

ReclutandoFase 3
  • Biopharma Informatic, LLC, Houston
  • Research Physicians Network LLC, Houston
Edades de 18 a 99 · Todos los sexos · Actualizado el 9 nov 2026 · NCT07871409

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

ReclutandoFase 3
  • Elevate Clinical, Houston
  • Houston Research Institute, Houston
  • Bellaire Clinical Research, LLC, Bellaire · A 7 mi de distancia
Edades de 18 en adelante · Todos los sexos · Actualizado el 9 nov 2026 · NCT07351045

Adapting and Assessing the Feasibility of a Telehealth Diabetes Prevention Program for Hispanic Adolescents

ReclutandoSe aceptan voluntarios sanosIndica pago para participantes
  • USDA/ARS Children's Nutrition Research Center, Baylor College of Medicine, Houston
Edades de 14 a 16 · Todos los sexos · Actualizado el 9 nov 2026 · NCT06943001

PATHS-UP Health Behavior Self-monitoring Mobile App for Adolescents

ReclutandoSe aceptan voluntarios sanos
  • Children's Nutrition Research Center, Houston
Edades de 12 a 18 · Todos los sexos · Actualizado el 9 nov 2026 · NCT06959901

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

ReclutandoFase 3
  • HRI ? Medical Center, LLC, Houston
  • Juno Research, LLC, Houston
Edades de 18 en adelante · Todos los sexos · Actualizado el 9 nov 2026 · NCT07351058

Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)

ReclutandoFase 3
  • Biopharma Informatic, LLC, Houston
  • Research Physicians Network, LLC, Houston
Edades de 18 a 99 · Todos los sexos · Actualizado el 6 nov 2026 · NCT07575399

A Study to Learn About Study Medicine Called Berobenatide in Adults With Knee Pain and Overweight or Obesity (VESPER-OA 1)

ReclutandoFase 3
  • JCCT-JUNO NW Houston, Houston
Edades de 18 en adelante · Todos los sexos · Actualizado el 5 nov 2026 · NCT07919678

A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity

ReclutandoFase 3
  • PlanIt Research, LLC (Monitoring Room), Houston
  • PlanIt Research, LLC, Houston
Edades de 18 en adelante · Todos los sexos · Actualizado el 5 nov 2026 · NCT07595549

A Study of EloraTZP in Adult Participants With Obesity or Overweight and Type 2 Diabetes

ReclutandoFase 3
  • Juno Research, Houston
  • Care Access - Houston - Clinical Trials Center by Walmart & Care Access, Houston
Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT07881458

A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)

ReclutandoFase 4
  • Center for Clinical Studies, Houston
  • Bellaire Dermatology Associates, Bellaire · A 7 mi de distancia
Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT06857942

Efficacy, Safety, and Pharmacokinetics of Tirzepatide (LY3298176) Once Weekly Versus Placebo in Pediatric Participants 6 to Less Than 12 Years of Age Who Have Obesity (ADVANCE-SURMOUNT-KIDS)

ReclutandoFase 3
  • McGovern Medical School, Houston
  • Texas Childrens Hospital, Houston
Edades de 6 a 11 · Todos los sexos · Actualizado el 4 nov 2026 · NCT07817875

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

ReclutandoFase 3
  • Juno Research, Houston
Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT07282600

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

ReclutandoFase 3
  • Juno Research, Houston
Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT07392190

Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight

ReclutandoFase 3
  • Care Access - Houston, Houston
  • JCCT - Juno Bellaire Site, Bellaire · A 7 mi de distancia
Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT07353931

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

ReclutandoFase 3
  • McGovern Medical School, Houston
  • Texas Childrens Hospital, Houston
  • Dynamed Clinical Research, LP d/b/a DM Clinical Research, Houston
  • y 1 más
Edades de 6 a 17 · Todos los sexos · Actualizado el 4 nov 2026 · NCT06672549

A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide

ReclutandoFase 2
  • Juno Research, Houston
Edades de 18 a 75 · Todos los sexos · Actualizado el 4 nov 2026 · NCT06897475

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

ReclutandoFase 2
  • Cardiovascular Specialists of Willowbrook, Houston
Edades de 18 en adelante · Todos los sexos · Actualizado el 3 nov 2026 · NCT07783802

A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus

ReclutandoFase 3
  • Research Site, Houston
Edades de 18 en adelante · Todos los sexos · Actualizado el 30 oct 2026 · NCT07784725

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

ReclutandoFase 3
  • East Texas Cardiology PA, Houston
  • Biopharma Informatic, Houston
  • Orion Medical, Houston
  • y 3 más
Edades de 18 a 99 · Todos los sexos · Actualizado el 29 oct 2026 · NCT07037459

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

ReclutandoFase 3
  • Research Site, Houston
Edades de 18 en adelante · Todos los sexos · Actualizado el 28 oct 2026 · NCT07784270

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

ReclutandoFase 2
  • Juno Research /ID# 282413, Houston
  • PlanIt Research /ID# 282204, Houston
  • JCCT - Juno Bellaire /ID# 282263, Bellaire · A 7 mi de distancia
Edades de 18 a 75 · Todos los sexos · Actualizado el 27 oct 2026 · NCT07752979

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

ReclutandoFase 3Se aceptan voluntarios sanos
  • ACCOMPLISH-2 Research Site, Houston
  • ACCOMPLISH-2 Research Site, Houston
Edades de 18 a 79 · Todos los sexos · Actualizado el 20 oct 2026 · NCT07654374

Metformin IN Asthma for Overweight and Obese Individuals (MINA)

ReclutandoFase 2
  • Baylor College of Medicine, Houston
Edades de 18 en adelante · Todos los sexos · Actualizado el 16 oct 2026 · NCT06273072

The RESET System Pivotal Clinical Trial (Protocol Revision K)

Reclutando
  • Baylor College of Medicine, Houston
  • Elevate Clinical Research, Houston, Houston
  • Elevate Clinical Research, Atascocita, Atascocita · A 20 mi de distancia
Edades de 22 a 65 · Todos los sexos · Actualizado el 13 oct 2026 · NCT04101669

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

ReclutandoFase 2
  • PlanIt Research, PLLC, Houston
Edades de 18 a 75 · Todos los sexos · Actualizado el 8 oct 2026 · NCT07589608

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

ReclutandoFase 2
  • PlanIt Research, PLLC, Houston
Edades de 18 a 75 · Todos los sexos · Actualizado el 7 oct 2026 · NCT06143956

Negative Pressure Wound Therapy in Healing Abdominal Incision in Obese Patients Undergoing Breast Reconstruction Surgery

Reclutando
  • M D Anderson Cancer Center, Houston
Edades de 18 en adelante · Mujeres · Actualizado el 7 oct 2026 · NCT04003038

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

ReclutandoFase 3
  • Biopharma Informatic, LLC, Houston
  • Johnson County Clinical Trials Juno Bellaire, Bellaire · A 7 mi de distancia
Edades de 18 a 99 · Todos los sexos · Actualizado el 5 oct 2026 · NCT07684235

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)

ReclutandoFase 3
  • Johnson County Clinical Trials Juno Bellaire, Bellaire · A 7 mi de distancia
Edades de 18 a 99 · Todos los sexos · Actualizado el 5 oct 2026 · NCT07684144

A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight

ReclutandoFase 3
  • DM Clinical, Houston
Edades de 8 a 18 · Todos los sexos · Actualizado el 30 sept 2026 · NCT07253285

A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide

ReclutandoFase 3
  • Houston Research Institute, Houston
  • The Endocrine Center, Houston
Edades de 18 en adelante · Todos los sexos · Actualizado el 28 sept 2026 · NCT07668414

A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes

ReclutandoFase 3
  • The University of Texas Health Science Center at Houston, Bellaire · A 7 mi de distancia
Edades de 18 en adelante · Todos los sexos · Actualizado el 22 sept 2026 · NCT07321886

Semaglutide for Post-Smoking Cessation Weight Management

ReclutandoFase 2Se aceptan voluntarios sanos
  • The University of Texas Health Science Center at Houston, Houston
Edades de 18 a 75 · Todos los sexos · Actualizado el 21 sept 2026 · NCT06173778

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

ReclutandoFase 3
  • AURORA-2 Clinical Site, Houston
Edades de 18 en adelante · Todos los sexos · Actualizado el 16 sept 2026 · NCT07743450

Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL

ReclutandoFase 2
  • Baylor Texas Children's Hospital, Houston
Edades de 7 a 25 · Todos los sexos · Actualizado el 19 ago 2026 · NCT05082519

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

ReclutandoFase 3
  • East Texas Cardiology PA, Houston
  • Victorium Clinical Research, Houston
  • Main Heart Clinic, Houston
  • y 1 más
Edades de 18 en adelante · Todos los sexos · Actualizado el 18 ago 2026 · NCT07567001

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

ReclutandoFase 3
  • ACCOMPLISH-1 Research Site, Houston
  • ACCOMPLISH-1 Research Site, Houston
Edades de 18 a 79 · Todos los sexos · Actualizado el 10 ago 2026 · NCT07654361

Determinants of Insulin Sensitivity by Age, Sex, Race/Ethnicity, BMI, and PCOS Diagnosis

ReclutandoEstudio observacionalSe aceptan voluntarios sanos
  • Lilli Health, Houston
Edades de 18 en adelante · Todos los sexos · Actualizado el 1 may 2026 · NCT05950282

Incretin Microdosing for Cardiometabolic Health in People With HIV

ReclutandoFase 2
  • The University of Texas Health Science Center at Houston, Houston
Edades de 18 en adelante · Todos los sexos · Actualizado el 18 feb 2026 · NCT07325500

Endoscopic Sleeve Gastroplasty (ESG) for the Treatment of Obesity

Reclutando
  • Houston Methodist Hospital, Houston
Edades de 18 en adelante · Todos los sexos · Actualizado el 1 abr 2024 · NCT06339320

Más información sobre Obesidad en MedlinePlus

Ensayos de Obesidad en otras ciudades

Otros estudios en Houston

De ClinicalTrials.gov, datos obtenidos el 15 nov 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.